Search
for
Sort by
Research 30 of 1000+
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- The Role of Janus Kinase Inhibitors in Dermatology
- New drugs under investigation for the treatment of alopecias
- Type 2 innate immunity regulates hair follicle homeostasis to control <i>Demodex</i> pathosymbionts
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Innate type 2 immunity controls hair follicle commensalism by Demodex mites
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Poster Presentations
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Dermal Adipocyte Lipolysis and Myofibroblast Conversion Are Required for Efficient Skin Repair
- Hepatocyte growth factor-modified hair follicle stem cells ameliorate cerebral ischemia/reperfusion injury in rats
- 490 Samcyprone (diphenylcyclopropenone ointment) for the treatment of common warts
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- ROS-scavenging microneedles loaded with <i>Portulaca oleracea</i> L.-derived exosomes for atopic dermatitis therapy
- Genetic links between atopy, allergy, and alopecia areata: insights from a Mendelian randomization study
- Novel drugs of United States Food and Drug Administration approved in 2024
- Langerin+ Dendritic Cells in Cutaneous Fibrosis: The TGF-β1 Signaling Axis
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- Efficacy of Dupilumab in Patients with Atopic Dermatitis and Alopecia Areata: A Case Series
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Multi-modal skin atlas identifies a multicellular immune-stromal community associated with disrupted cornification and specific T cell expansion in atopic dermatitis
- Cell death in skin function, inflammation, and disease
- Human umbilical cord mesenchymal stem cell treatment alleviates symptoms in an atopic dermatitis-like mouse model
- The regenerative potential of skin and the immune system